OTCPK:MEDVF - Post by User
Comment by
GeneralWolfeon Nov 26, 2021 6:28am
109 Views
Post# 34167754
RE:RE:MEDV is Creating value. FACT
RE:RE:MEDV is Creating value. FACT NO, not the case at all. You are lying again... lolll, but nice try. Again, just facts. Some of the MEDV highlights from the zoom call. -Share Consolidation Passed - R/S was addressed and is “only” if needed to uplist but is not a priority they feel they can hit targets based on increasing and projected revenue going into 2022 -They are on pace for their projected revenue of 60M for 2021 (*From invester deck, looking at Q3 we could very well pass 60 million) -Spoke on Q4: "We anticipate to be just as good if not significantly better than Q3, trend it going in the right direction. Maybe a dip in November, fluctuation of business (10-15% dip from absolute peak)." *Q3 Revenue was $25.3 Million -Spoke to their software ,Govt asking for even more testing, different tests coming at locations, influenza and other tests, Focusing on expanding platforms with AI , Cholesterol and diabetes tech, prescriptions. -States MEDV is grossly undervalued, Says to deal with shorts by producing revenue results and increasing them.